The number of competitors developing and marketing cell therapy and tissue engineering products is extraordinary. But since approved clinical applications are proliferating and the resulting market has been driving dramatic double-digit-plus growth, it's unsurprising that competitors from extreme sides of the medical technology industry — drug, device, and biotech — are converging on this lucrative arena.
Current competitors driving revenues are finding windfalls, spawning aggressive development of products by emerging competitors.
See the February 2010 Report #S520 , Worldwide Market for Tissue Engineering and Cell Therapy, 2009-2018." by MedMarket Diligence, LLC.